ID   AK1A1_HUMAN             Reviewed;         325 AA.
AC   P14550; A8KAL8; D3DQ04; Q6IAZ4;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   15-MAR-2017, entry version 179.
DE   RecName: Full=Alcohol dehydrogenase [NADP(+)];
DE            EC=1.1.1.2;
DE   AltName: Full=Aldehyde reductase;
DE   AltName: Full=Aldo-keto reductase family 1 member A1;
GN   Name=AKR1A1; Synonyms=ALDR1, ALR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Liver;
RX   PubMed=2498333;
RA   Bohren K.M., Bullock B., Wermuth B., Gabbay K.H.;
RT   "The aldo-keto reductase superfamily. cDNAs and deduced amino acid
RT   sequences of human aldehyde and aldose reductases.";
RL   J. Biol. Chem. 264:9547-9551(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10393438;
RA   Fujii J., Hamaoka R., Matsumoto A., Fujii T., Yamaguchi Y.,
RA   Egashira M., Miyoshi O., Niikawa N., Taniguchi N.;
RT   "The structural organization of the human aldehyde reductase gene,
RT   AKR1A1, and mapping to chromosome 1p33-->p32.";
RL   Cytogenet. Cell Genet. 84:230-232(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10486210; DOI=10.1006/geno.1999.5915;
RA   Barski O.A., Gabbay K.H., Bohren K.M.;
RT   "Characterization of the human aldehyde reductase gene and promoter.";
RL   Genomics 60:188-198(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   PROTEIN SEQUENCE OF 2-325.
RC   TISSUE=Liver;
RX   PubMed=3615425;
RA   Wermuth B., Omar A., Forster A., di Francesco C., Wolf M.,
RA   von Wartburg J.-P., Bullock B., Gabbay K.H.;
RT   "Primary structure of aldehyde reductase from human liver.";
RL   Prog. Clin. Biol. Res. 232:297-307(1987).
RN   [11]
RP   MUTAGENESIS OF TYR-50; LYS-80; HIS-113; ILE-299 AND VAL-300.
RX   PubMed=7669785; DOI=10.1021/bi00035a036;
RA   Barski O.A., Gabbay K.H., Grimshaw C.E., Bohren K.M.;
RT   "Mechanism of human aldehyde reductase: characterization of the active
RT   site pocket.";
RL   Biochemistry 34:11264-11275(1995).
RN   [12]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=10510318; DOI=10.1042/bj3430487;
RA   O'Connor T., Ireland L.S., Harrison D.J., Hayes J.D.;
RT   "Major differences exist in the function and tissue-specific
RT   expression of human aflatoxin B1 aldehyde reductase and the principal
RT   human aldo-keto reductase AKR1 family members.";
RL   Biochem. J. 343:487-504(1999).
RN   [13]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=11306097; DOI=10.1016/S0009-2797(00)00237-4;
RA   Palackal N.T., Burczynski M.E., Harvey R.G., Penning T.M.;
RT   "Metabolic activation of polycyclic aromatic hydrocarbon trans-
RT   dihydrodiols by ubiquitously expressed aldehyde reductase (AKR1A1).";
RL   Chem. Biol. Interact. 130:815-824(2001).
RN   [14]
RP   FUNCTION, AND CHARACTERIZATION OF VARIANTS SER-52 AND ASP-55.
RX   PubMed=18276838; DOI=10.1124/dmd.107.018895;
RA   Bains O.S., Takahashi R.H., Pfeifer T.A., Grigliatti T.A., Reid R.E.,
RA   Riggs K.W.;
RT   "Two allelic variants of aldo-keto reductase 1A1 exhibit reduced in
RT   vitro metabolism of daunorubicin.";
RL   Drug Metab. Dispos. 36:904-910(2008).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-211, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-38, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.48 ANGSTROMS).
RX   PubMed=15299353; DOI=10.1107/S0907444994005275;
RA   El-Kabbani O., Green N.C., Lin G., Carson M., Narayana S.V.L.,
RA   Moore K.M., Flynn T.G., DeLucas L.J.;
RT   "Structures of human and porcine aldehyde reductase: an enzyme
RT   implicated in diabetic complications.";
RL   Acta Crystallogr. D 50:859-868(1994).
CC   -!- FUNCTION: Catalyzes the NADPH-dependent reduction of a variety of
CC       aromatic and aliphatic aldehydes to their corresponding alcohols.
CC       Catalyzes the reduction of mevaldate to mevalonic acid and of
CC       glyceraldehyde to glycerol. Has broad substrate specificity. In
CC       vitro substrates include succinic semialdehyde, 4-
CC       nitrobenzaldehyde, 1,2-naphthoquinone, methylglyoxal, and D-
CC       glucuronic acid. Plays a role in the activation of procarcinogens,
CC       such as polycyclic aromatic hydrocarbon trans-dihydrodiols, and in
CC       the metabolism of various xenobiotics and drugs, including the
CC       anthracyclines doxorubicin (DOX) and daunorubicin (DAUN).
CC       {ECO:0000269|PubMed:10510318, ECO:0000269|PubMed:11306097,
CC       ECO:0000269|PubMed:18276838}.
CC   -!- CATALYTIC ACTIVITY: An alcohol + NADP(+) = an aldehyde + NADPH.
CC   -!- SUBUNIT: Monomer. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q9NYB0:TERF2IP; NbExp=2; IntAct=EBI-372388, EBI-750109;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highly expressed in kidney,
CC       salivary gland and liver. Detected in trachea, stomach, brain,
CC       lung, prostate, placenta, mammary gland, small intestine and lung.
CC       {ECO:0000269|PubMed:10510318, ECO:0000269|PubMed:11306097}.
CC   -!- SIMILARITY: Belongs to the aldo/keto reductase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J04794; AAA51711.1; -; mRNA.
DR   EMBL; AF036683; AAB92369.1; -; Genomic_DNA.
DR   EMBL; AF036680; AAB92369.1; JOINED; Genomic_DNA.
DR   EMBL; AF036681; AAB92369.1; JOINED; Genomic_DNA.
DR   EMBL; AF036682; AAB92369.1; JOINED; Genomic_DNA.
DR   EMBL; AF112485; AAF01260.1; -; Genomic_DNA.
DR   EMBL; AF112484; AAF01260.1; JOINED; Genomic_DNA.
DR   EMBL; AK293083; BAF85772.1; -; mRNA.
DR   EMBL; CR457010; CAG33291.1; -; mRNA.
DR   EMBL; BT007003; AAP35649.1; -; mRNA.
DR   EMBL; AL355480; CAI22459.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX06970.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX06971.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX06972.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX06974.1; -; Genomic_DNA.
DR   EMBL; BC000670; AAH00670.1; -; mRNA.
DR   EMBL; BC005394; AAH05394.1; -; mRNA.
DR   CCDS; CCDS523.1; -.
DR   PIR; A33851; A33851.
DR   RefSeq; NP_001189342.1; NM_001202413.1.
DR   RefSeq; NP_001189343.1; NM_001202414.1.
DR   RefSeq; NP_006057.1; NM_006066.3.
DR   RefSeq; NP_697021.1; NM_153326.2.
DR   UniGene; Hs.474584; -.
DR   UniGene; Hs.721160; -.
DR   PDB; 2ALR; X-ray; 2.48 A; A=2-325.
DR   PDBsum; 2ALR; -.
DR   ProteinModelPortal; P14550; -.
DR   SMR; P14550; -.
DR   BioGrid; 115610; 28.
DR   IntAct; P14550; 4.
DR   MINT; MINT-5001699; -.
DR   STRING; 9606.ENSP00000312606; -.
DR   BindingDB; P14550; -.
DR   ChEMBL; CHEMBL2246; -.
DR   DrugBank; DB03461; 2'-Monophosphoadenosine 5'-Diphosphoribose.
DR   DrugBank; DB00997; Doxorubicin.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB00157; NADH.
DR   DrugBank; DB02383; Tolrestat.
DR   iPTMnet; P14550; -.
DR   PhosphoSitePlus; P14550; -.
DR   SwissPalm; P14550; -.
DR   BioMuta; AKR1A1; -.
DR   DMDM; 113600; -.
DR   REPRODUCTION-2DPAGE; IPI00220271; -.
DR   REPRODUCTION-2DPAGE; P14550; -.
DR   SWISS-2DPAGE; P14550; -.
DR   UCD-2DPAGE; P14550; -.
DR   EPD; P14550; -.
DR   PaxDb; P14550; -.
DR   PeptideAtlas; P14550; -.
DR   PRIDE; P14550; -.
DR   DNASU; 10327; -.
DR   Ensembl; ENST00000351829; ENSP00000312606; ENSG00000117448.
DR   Ensembl; ENST00000372070; ENSP00000361140; ENSG00000117448.
DR   Ensembl; ENST00000621846; ENSP00000480713; ENSG00000117448.
DR   GeneID; 10327; -.
DR   KEGG; hsa:10327; -.
DR   CTD; 10327; -.
DR   DisGeNET; 10327; -.
DR   GeneCards; AKR1A1; -.
DR   HGNC; HGNC:380; AKR1A1.
DR   HPA; CAB006246; -.
DR   HPA; HPA017919; -.
DR   HPA; HPA019649; -.
DR   HPA; HPA027734; -.
DR   MIM; 103830; gene.
DR   neXtProt; NX_P14550; -.
DR   OpenTargets; ENSG00000117448; -.
DR   PharmGKB; PA24674; -.
DR   eggNOG; KOG1577; Eukaryota.
DR   eggNOG; COG0656; LUCA.
DR   GeneTree; ENSGT00760000119041; -.
DR   HOGENOM; HOG000250272; -.
DR   HOVERGEN; HBG000020; -.
DR   InParanoid; P14550; -.
DR   KO; K00002; -.
DR   OMA; WDALEKI; -.
DR   OrthoDB; EOG091G0D69; -.
DR   PhylomeDB; P14550; -.
DR   TreeFam; TF106492; -.
DR   BRENDA; 1.1.1.2; 2681.
DR   Reactome; R-HSA-156590; Glutathione conjugation.
DR   Reactome; R-HSA-5661270; Catabolism of glucuronate to xylulose-5-phosphate.
DR   SABIO-RK; P14550; -.
DR   ChiTaRS; AKR1A1; human.
DR   EvolutionaryTrace; P14550; -.
DR   GeneWiki; Aldo-keto_reductase_family_1,_member_A1; -.
DR   GenomeRNAi; 10327; -.
DR   PRO; PR:P14550; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000117448; -.
DR   CleanEx; HS_AKR1A1; -.
DR   ExpressionAtlas; P14550; baseline and differential.
DR   Genevisible; P14550; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0004032; F:alditol:NADP+ 1-oxidoreductase activity; TAS:ProtInc.
DR   GO; GO:0004033; F:aldo-keto reductase (NADP) activity; TAS:Reactome.
DR   GO; GO:0009055; F:electron carrier activity; TAS:UniProtKB.
DR   GO; GO:0047939; F:L-glucuronate reductase activity; EXP:Reactome.
DR   GO; GO:0046185; P:aldehyde catabolic process; IEA:Ensembl.
DR   GO; GO:0006081; P:cellular aldehyde metabolic process; TAS:ProtInc.
DR   GO; GO:0042840; P:D-glucuronate catabolic process; IEA:Ensembl.
DR   GO; GO:0006006; P:glucose metabolic process; TAS:ProtInc.
DR   GO; GO:0019640; P:glucuronate catabolic process to xylulose 5-phosphate; TAS:Reactome.
DR   GO; GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome.
DR   GO; GO:0019853; P:L-ascorbic acid biosynthetic process; IEA:Ensembl.
DR   CDD; cd06660; Aldo_ket_red; 1.
DR   Gene3D; 3.20.20.100; -; 1.
DR   InterPro; IPR018170; Aldo/ket_reductase_CS.
DR   InterPro; IPR020471; Aldo/keto_reductase.
DR   InterPro; IPR023210; NADP_OxRdtase_dom.
DR   PANTHER; PTHR11732; PTHR11732; 1.
DR   Pfam; PF00248; Aldo_ket_red; 1.
DR   PIRSF; PIRSF000097; AKR; 1.
DR   PRINTS; PR00069; ALDKETRDTASE.
DR   SUPFAM; SSF51430; SSF51430; 1.
DR   PROSITE; PS00798; ALDOKETO_REDUCTASE_1; 1.
DR   PROSITE; PS00062; ALDOKETO_REDUCTASE_2; 1.
DR   PROSITE; PS00063; ALDOKETO_REDUCTASE_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome;
KW   Direct protein sequencing; NADP; Oxidoreductase; Phosphoprotein;
KW   Polymorphism; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|PubMed:3615425}.
FT   CHAIN         2    325       Alcohol dehydrogenase [NADP(+)].
FT                                /FTId=PRO_0000124617.
FT   NP_BIND      21     23       NADP. {ECO:0000250|UniProtKB:O60218}.
FT   NP_BIND     162    163       NADP. {ECO:0000250|UniProtKB:O60218}.
FT   NP_BIND     210    217       NADP. {ECO:0000250|UniProtKB:O60218}.
FT   NP_BIND     261    273       NADP. {ECO:0000250|UniProtKB:O60218}.
FT   ACT_SITE     50     50       Proton donor.
FT                                {ECO:0000269|PubMed:7669785}.
FT   BINDING      45     45       NADP. {ECO:0000250|UniProtKB:O60218}.
FT   BINDING     113    113       Substrate. {ECO:0000269|PubMed:7669785}.
FT   BINDING     184    184       NADP. {ECO:0000250|UniProtKB:O60218}.
FT   SITE         80     80       Lowers pKa of active site Tyr.
FT                                {ECO:0000269|PubMed:7669785}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:25944712}.
FT   MOD_RES       4      4       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P51635}.
FT   MOD_RES      38     38       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     127    127       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9JII6}.
FT   MOD_RES     127    127       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9JII6}.
FT   MOD_RES     145    145       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9JII6}.
FT   MOD_RES     211    211       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT      52     52       N -> S (reduced activity towards
FT                                daunorubicin; dbSNP:rs2229540).
FT                                {ECO:0000269|PubMed:18276838}.
FT                                /FTId=VAR_048212.
FT   VARIANT      55     55       E -> D (reduced activity towards
FT                                daunorubicin; dbSNP:rs6690497).
FT                                {ECO:0000269|PubMed:18276838}.
FT                                /FTId=VAR_058909.
FT   MUTAGEN      50     50       Y->F: Complete loss of enzymatic
FT                                activity. {ECO:0000269|PubMed:7669785}.
FT   MUTAGEN      50     50       Y->H: Complete loss of enzymatic
FT                                activity. {ECO:0000269|PubMed:7669785}.
FT   MUTAGEN      80     80       K->M: Complete loss of enzymatic
FT                                activity. {ECO:0000269|PubMed:7669785}.
FT   MUTAGEN     113    113       H->Q: Strong decrease in enzymatic
FT                                activity. {ECO:0000269|PubMed:7669785}.
FT   MUTAGEN     299    299       I->A: No change in enzymatic activity.
FT                                {ECO:0000269|PubMed:7669785}.
FT   MUTAGEN     299    299       I->C: No change in enzymatic activity.
FT                                {ECO:0000269|PubMed:7669785}.
FT   MUTAGEN     300    300       V->C: No change in enzymatic activity.
FT                                {ECO:0000269|PubMed:7669785}.
FT   CONFLICT    305    305       V -> A (in Ref. 4; BAF85772).
FT                                {ECO:0000305}.
FT   STRAND        5      7       {ECO:0000244|PDB:2ALR}.
FT   STRAND       13     17       {ECO:0000244|PDB:2ALR}.
FT   HELIX        26     39       {ECO:0000244|PDB:2ALR}.
FT   STRAND       43     45       {ECO:0000244|PDB:2ALR}.
FT   HELIX        48     50       {ECO:0000244|PDB:2ALR}.
FT   HELIX        53     63       {ECO:0000244|PDB:2ALR}.
FT   STRAND       68     70       {ECO:0000244|PDB:2ALR}.
FT   HELIX        72     74       {ECO:0000244|PDB:2ALR}.
FT   STRAND       76     81       {ECO:0000244|PDB:2ALR}.
FT   HELIX        83     85       {ECO:0000244|PDB:2ALR}.
FT   HELIX        88    102       {ECO:0000244|PDB:2ALR}.
FT   STRAND      107    113       {ECO:0000244|PDB:2ALR}.
FT   STRAND      115    118       {ECO:0000244|PDB:2ALR}.
FT   STRAND      120    122       {ECO:0000244|PDB:2ALR}.
FT   HELIX       140    153       {ECO:0000244|PDB:2ALR}.
FT   STRAND      155    163       {ECO:0000244|PDB:2ALR}.
FT   HELIX       166    173       {ECO:0000244|PDB:2ALR}.
FT   STRAND      182    186       {ECO:0000244|PDB:2ALR}.
FT   HELIX       194    203       {ECO:0000244|PDB:2ALR}.
FT   STRAND      206    210       {ECO:0000244|PDB:2ALR}.
FT   HELIX       232    241       {ECO:0000244|PDB:2ALR}.
FT   HELIX       245    255       {ECO:0000244|PDB:2ALR}.
FT   HELIX       267    274       {ECO:0000244|PDB:2ALR}.
FT   HELIX       283    290       {ECO:0000244|PDB:2ALR}.
FT   STRAND      302    305       {ECO:0000244|PDB:2ALR}.
FT   STRAND      308    313       {ECO:0000244|PDB:2ALR}.
FT   STRAND      320    323       {ECO:0000244|PDB:2ALR}.
SQ   SEQUENCE   325 AA;  36573 MW;  F6B27517EB754E37 CRC64;
     MAASCVLLHT GQKMPLIGLG TWKSEPGQVK AAVKYALSVG YRHIDCAAIY GNEPEIGEAL
     KEDVGPGKAV PREELFVTSK LWNTKHHPED VEPALRKTLA DLQLEYLDLY LMHWPYAFER
     GDNPFPKNAD GTICYDSTHY KETWKALEAL VAKGLVQALG LSNFNSRQID DILSVASVRP
     AVLQVECHPY LAQNELIAHC QARGLEVTAY SPLGSSDRAW RDPDEPVLLE EPVVLALAEK
     YGRSPAQILL RWQVQRKVIC IPKSITPSRI LQNIKVFDFT FSPEEMKQLN ALNKNWRYIV
     PMLTVDGKRV PRDAGHPLYP FNDPY
//
